Search

You searched for "VUR"

451 results found

Quality Improvement – how to get involved?

1 November 2018 | | URO - Core Urology
The General Medical Council (GMC) requires all trainee doctors to carry out Quality Improvement (QI) as part of our annual appraisal process [1]. Exactly what QI projects are and how to get involved is less widely understood. Traditionally surgical trainees...

Shared decision-making – minimising the mismatch

3 May 2024 | | URO - Andrology, URO - Basic Science Research, URO - Endourology & Stones, URO - Infection, URO - Functional / Reconstructive Urology, URO - Neurourology, URO - Paediatric Urology, URO - Trauma & Emergency, URO - Urologic Oncology, URO - Uroradiology
In Western countries, we are spoilt for choice in almost every aspect of our lives, but does that reflect also in healthcare? While we have taken some big strides towards shared decision-making with our patients, the age-old physician dominance remains...

Mentorship and its role in surgical training

6 November 2020 | | URO - Core Urology
Is there a principle which could help address multiple challenges in surgical training? One which has potential to improve recruitment and retention of staff to our specialty, quality of patient care and surgeon morale? The author discusses the past present...

In conversation with Carmel Ramage

26 November 2025 | URO - Core Urology
Carmel Ramage. Can you tell us a little bit about what first attracted you to medicine and then what led you to specialise in urogynaecology? To be honest, I’m not sure I ever really made a conscious decision about my...

The management of renal calculi – Pt 1

1 March 2018 | | URO - Endourology & Stones
Renal calculi can be managed according to four treatment options: conservative management, extracorporeal shockwave lithotripsy (ESWL), flexible ureterorenoscopy (FURS) and percutaneous nephrolithotomy (PCNL). This is the first in a two-part series in Urology News (Part 2 available here) that will...

Men with a susceptibility to prostate cancer: implications of family history in PCa risk-prediction

3 September 2021 | | URO - Urologic Oncology
Incorporation of family history (FH) status into prostate cancer (PCa) risk stratification has the potential to underpin many aspects of PCa care. This group of men presents a unique challenge in early cancer detection, particularly given that most men without...

Urethroplasty: a review of indications, techniques and outcomes

1 March 2018 | | URO - Functional / Reconstructive Urology
Urethral stricture is the most common cause of lower urinary tract obstruction in men aged between 20 and 40, carrying an estimated overall prevalence of 0.5% in the UK [1] and results in around 17,000 hospital admissions annually [2]. Endoscopic...

Complications of CISC

1 July 2014 | | URO - Infection, URO - Functional / Reconstructive Urology, URO - Neurourology
Introduction Clean intermittent self catheterisation (CISC) was first introduced and popularised by Lapides in 1972. Since then its utilisation has become widespread and it is now commonly used throughout the world as the preferred means of facilitating complete and effective...

Urinary biomarkers for surveillance of non-muscle invasive bladder cancer

1 May 2019 | | URO - Basic Science Research, URO - Urologic Oncology
Bladder cancer (BC) is the ninth most common cancer worldwide with a yearly incidence of approximately 430,000 cases. There is a male predominance and it is the seventh most common cancer in men worldwide [1]. Non-muscle invasive bladder cancer (NMIBC)...

New distributor appointed for Urethrotech UCD

4 November 2019 | Company Profiles
Urethrotech® Ltd., who develop innovative solutions for safe lower urinary tract instrumentation, have appointed Pennine Healthcare as their exclusive distributor in the United Kingdom and the Republic of Ireland.

PROSPACKS supports prostate cancer patients starting treatment in Scotland

22 April 2025
Men across Scotland undergoing treatment for prostate cancer can benefit from new care and support packs thanks to a project by charity Prostate Scotland and long-term funder, the Grand Lodge of Scotland. PROSPACKS – tailored packs for men beginning radiotherapy,...

The PROMIS trial – time for multi-parametric MRI before a first prostate biopsy

1 March 2017 | | URO - Uroradiology, URO - Urologic Oncology
Whilst the relatively random process of 12 core transrectal ultrasound guided (TRUS) prostate biopsy remains by far the most widely employed approach to prostate cancer diagnosis in the UK, its flaws as a standalone diagnostic strategy are increasingly apparent. TRUS-biopsy...